The IMA Group Acquires Exemplar Research, Inc.

The IMA Group Acquires Accelemed Research Institute

April 11, 2023

Healthcare Services

The IMA Group (IMA Clinical Research) has acquired Accelemed Research Institute, a clinical research site in Austin, Texas, expanding IMA's footprint in the Southwest to more than 20 sites. The acquisition deepens IMA's capabilities in multi-therapeutic clinical trials—particularly cardiometabolic and GI indications—and keeps Accelemed operating under its current name with existing leadership retained.

The IMA Group Acquires Amici Clinical Research

March 2, 2022

Healthcare Services

The IMA Group's Clinical Research division acquired Amici Clinical Research, adding two New Jersey clinical trial sites (Raritan and Hoboken) to IMA's network. The acquisition expands IMA's Northeast footprint and therapeutic capabilities across areas including fatty liver, cardiovascular, pulmonary and neurologic diseases, and supports site-based, hybrid and decentralized trials.

The IMA Group Acquires Clinical Trials of America

January 11, 2023

Healthcare Services

The IMA Group’s clinical research division, IMA Clinical Research, has acquired Clinical Trials of America (CTA), adding 10 site locations (four independent and six embedded) and expanding IMA’s reach in Louisiana and North Carolina. CTA will continue to operate under existing leadership, and the deal increases IMA’s clinical network and therapeutic capabilities to better serve sponsors and CROs; terms were not disclosed.

The IMA Group Acquires EVOnational

February 23, 2021

Healthcare Services

The IMA Group, a technology-driven provider of medical and psychological evaluations, has acquired EVOnational, a national provider of independent medical exams (IMEs), medical screenings and other evaluations. The acquisition — terms not disclosed — adds more than 7,000 clinicians to IMA's provider panel, expands IMA's behavioral and medical evaluation capabilities, and will see EVOnational continue to operate under its current name with existing leadership retained.

Eximia Research Network Acquires Tidewater Clinical Research

August 2, 2024

Healthcare Services

Eximia Research Network has acquired Tidewater Clinical Research, integrating the Virginia-based clinical trial site into its national network to expand geographic reach and therapeutic capabilities. The deal brings Tidewater's long-standing expertise in Women's Health and Ophthalmology and a ~97,000-patient database into Eximia's PE-backed platform (investor: VSS Capital Partners); Viking Mergers & Acquisitions advised the sellers.

The IMA Group Acquires Chicago Research Center

October 8, 2025

Healthcare Services

The IMA Group (IMA Clinical Research), a PE-backed national clinical research platform, has acquired Chicago Research Center (CRC), an independent clinical research site in Chicago specializing in CNS and sleep disorder trials. The deal expands IMA's geographic footprint and capabilities—marking its first dedicated sleep research site—and will keep CRC's leadership and staff in place to support Phase I–IV trials.